Clinical-stage gene therapy company Genprex (NASDAQ: GNPX) this morning announced that it will present, via webcast, at the Singular Research Midwestern Values Conference on September 19, 2019. Genprex Chairman and CEO Rodney Varner will lead…
Organigram Holdings (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading licensed producer of cannabis, was recently highlighted in an article by Bloomberg titled, ‘Organigram a Canadian Pot Rarity After Four Profitable…
ChineseInvestors.com is a leading financial information website for Chinese-speaking investors The company reported a 175 percent year-over-year increase in revenue for FY2019 CIIX’s CBD Biotech Inc. division recently launched six new skincare products ChineseInvestors.com Inc.…
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced that Daniel J. Shea has joined the…
INmune Bio (NASDAQ: INMB), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today announced that RJ Tesi, M.D., Co-Founder and CEO, and Mark Lowdell, Ph.D.,…
Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced that its portfolio company TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF) has entered into a distribution agreement with Israel-based pharma-tech company…
Global innovator in drug delivery platforms Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) today announced the publication of final study results of the 2018 human clinical study evaluating CBD delivery and effectiveness using its patented…
SRAX has developed an exclusive consumer-managed data marketplace The company offers its proprietary BIGtoken platform SRAX has entered into new partnerships to launch BIGtoken’s BIG Rewards(TM) SRAX Inc. (NASDAQ: SRAX) is a digital-marketing and data…
The company delivers premium, certified organic cannabis to Canada and international markets TGOD intends to explore strategic international markets with exclusive licensing deals and partnerships The company has set its sights on the beverage industry…
Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), an innovative biotechnology company, has set its sights on using its proprietary drug delivery technology to provide an alternative method of nicotine ingestion that is safer than smoking. An…
INmune Bio (NASDAQ: INMB), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today announced its receipt of United States Patent and Trademark Office (“USPTO”) formal…
Cannabis-focused research and development company The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium certified organic cannabis, today announced that initial demand has exceeded expectations following its August launch in…
BMO’s block offering of TGOD’s shares was fully subscribed TGOD’s CEO commented on the mutual benefits presented by the Aurora transaction Investment interest in TGOD has been heightened following completion of the transaction In the…
Clinical-stage gene therapy company Genprex (NASDAQ: GNPX) this morning announced that non-affiliated, independent researchers have reported in a recent study that TUSC2, a tumor suppressor gene and the active agent in Genprex’s Oncoprex(TM) immunogene therapy,…
Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced the formation of its Strategic Advisory Board. According to the update, the group of respected business leaders, which includes inaugural…
Pressure BioSciences Inc. (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced the publication of two scientific journal…
Earth Science Tech is looking to expand its line of work through two wholly owned subsidiaries Its subsidiaries focus on R&D and product development The company recently outlined a five-year marketing and manufacturing plan Earth…
Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced that its portfolio company Herbert Works Ltd. has received its Health Canada research and development (R&D) license to develop branded…
Digital marketing and consumer data management technology company SRAX (NASDAQ: SRAX) today announced its entry into new partnerships with major consumer packaged goods (“CPG”) brands to launch BIG Rewards(TM). According to the update, BIG Rewards(TM)…
Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, this morning announced that its class A subordinated voting shares began trading on the Toronto Stock Exchange (the “TSX”) under the…